Author:
Nakajima Daisuke,Yagishita Mayuko
Reference26 articles.
1. Asada S, Sasaki K, Tanaka N, Takeda K, Hayashi M, Umeda M (2005) Detection of initiating as well as promoting activity of chemicals by a novel cell transformation assay using v-Ha-ras-transfected BALB/c 3T3 cells (Bhas 42 cells). Mutat Res 588:7–21
2. Audebert M, Zeman F, Beaudoin R, Péry A, Cravedi JP (2012) Comparative potency approach based on H2AX assay for estimating the genotoxicity of polycyclic aromatic hydrocarbons. Toxicol Appl Pharmacol 260:58–64
3. Chu MML, Chen CW (1984) Evaluation and estimation of potential carcinogenic risks of polynuclear aromatic hydrocarbons. Presented at the Symposium on Polycyclic Aromatic Hydrocarbons in the Workplace; Pacific Rim Risk conference, Honolulu, HI, USA
4. Clement (1988) Comparative potency approach for estimating the cancer risk associated with exposure to mixtures of polycyclic aromatic hydrocarbons (Interim Final Report). Prepared for EPA under Contract 68-02-4403; ICF-Clement Associates: Fairfax, VA, USA, April 1988
5. Collins JF, Brown JP, Alexeeff GV, Salmon AG (1998) Potency equivalency factors for some polycyclic aromatic hydrocarbons and polycyclic aromatic hydrocarbon derivatives. Regul Toxicol Pharmacol 28:45–54